The Misuse of Opiate Substitution Therapy: an Obstacle for the Diffusion of Best Practice in Italy Lisbon, 23 September 2015
|
|
|
- Morgan Morris
- 5 years ago
- Views:
Transcription
1 + Felice Nava, MD, PhD Director Penitentiary Medicine Padua, Italy Vice-President Italian Society of Addiction Medicine The Misuse of Opiate Substitution Therapy: an Obstacle for the Diffusion of Best Practice in Italy Lisbon, 23 September 2015
2 Italian Detainees -25% (13.488) drug users (only 10% in probation) -17% (9.495) drug addicts -10% (1.331) alcoholics % HCV HBV 15.4% - 3.9% HIV - irregular infective screening ( %) -Overcrowing (reduced by 30% in the last year) -Closing Criminal Psychiatric Hospital Source: Ministry of Justice, 2014 Report to Parliament, 2015
3 The Dark Side of the Moon for the Italian Treatments of Prison Drug Users 550 Drug Abuse Units (Ser.D) 203 Prison Drug Abuse Units No data on efficacy of agonist therapy in prison No official guidelines for treatment for detainees drug users (e.g. for OST) No official guidelines for harm reduction measures in prisons
4 The Pride Project: Italian Data % adherent to WHO guidelines Opioid Substitution Therapy - Induction at entry (RC) + induction during prison stay + continuity of OST at entry - No ceiling dosage - No BHD crushing or dilution Needles exchange Measures for safer sex and drug use 14.3 (n = 5) 34.3 ( n = 12) 85.7 (n = 30) 48.6 (n =17) NA NA 35/203 prisons (17.24%) 32 Remand Prisons 3 Sentece Prisons 2 Juvenile Prison /62.53 detainees (22.75%)
5 The Pride Project in Italy: Results Gap between Italian and WHO Guidelines on Harm Reduction Measures in Prisons
6 Focus on Agonist Therapy in Prison: Few Diagnosed Heroin Addicts and OSTs Diversion: 53% ( n = 112) The terms misuse and abuse refer to the use of drugs either alone or in combinaion with others, to attain euphoria or get high, and also refer to instances of drugs in a dangerous manner (e.g. by i.v. administration) The term diversion refers to the act of redirecting a drug from legitimate sources to illegitamate or illegal ones FeDerSerD data, 2014
7 Focus on Therapy Agonist in Prison: Low Doses and Too Brief Treatments FeDerSerD data, 2014
8 (Mis)use of BDZs in Italian Prison Population Data from 35 Italian Prisons (14,229 detainees) 57% of detainees misuse BDZs (in high doses and for long term period) 85% of detainees with addiction and/or psychiatric problems misuse BDZs FeDerSerD Data, 2014
9 Most BDZs mis(use) in Italian Prisons BDZ % of Use Lormetazepam 45% Clonazepam 23% Lorazepam 18% Alprazolam 7% Other BDZs 7% FeDerSerD Data, 2014
10 The Economic Cost of Society for the Bad Use of Agonist Therapy in Prison Cost of methadone treatment for 1 year Cost of imprisoment for 1 year $4,700 1,056 $24,000 72,000
11 Conclusion Improve the quality (increase of the dose and of the length of the treatments) and the number of agonist treatments in prison Potentiate the measures of harm reductions: Change the Laws on Drugs (e.g. decriminalizing cannabis use and increasing the funds on harm reduction measures) Introduce the evidence based medicine in prisons as instrument to reduce misuse and diversion of OST
12 References Agreement Sate Regions, HIV Infection in Prison, Rome, 15 March 2012 Italian Law on Drugs, DPR 309/90 and further modifications DPA, Measures and Concrete Actions for the Prevention of Drug Related Diseases, Department of Antidrug Policies, Rome, June 2009 DPA, Lines of actions on Addiction and Prisons, Department of Antidrug Policies, Rome, November 2011; DPA, Report to Parliament on Drug Use, Department of Antidrug Policies. Sagnelli E, Starnini G., Sagnelli C., Monarca R., Zumbo G., Pontali E., Gabbutti A., Carbonara S., Iardino R., Armagnacco O., Babudieri S., SIMPSE Group, Blood borne viral infection, sexually transmitted diseases and latent tubercolosis in Italian prisons: a preliminary report of a large multicentric study, Eur. Rev., Med. Pharmacol. Sci., 16: WHO, Effectiveness of interventions to address HIV in prisons. Evidence for action technical paper, Geneva, WHO-UNODC-UNAIDS. UNODC, HIV prevention, treatment and care in prisons and other closed setting: a comprensive package of intervention, Vienna.
13 Felice Nava, MD, PhD Director Penitentiaty Medicine Local Health Unit Padua Italy Tel Fax Vice President FeDerSerD (Italian Society of Addiction Medicine) nava.it
Models of good practice in drug treatment in Europe. Project group
Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
Monitoring harm reduction implementation in European prisons: public health and human rights approaches
Monitoring harm reduction implementation in European prisons: public health and human rights approaches Cinzia Brentari, Harm Reduction International ~ 14 June 2015 ~ cinzia.brentari@ihra.net www.ihra.net
Medical Director. and in prison settings in Romania. Ministry of Justice National Administration of Penitentiaries L IŢ
Dr. Geta Cucu edical Director Romanian National Administration of Penitentiaries Dr. ihai Corciova Expert UNODC Project - HIV/AIDS prevention and care among IDUs and in prison settings in Romania inistry
KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA
KAZAKHSTAN Territory : 2,717,300 km 2 Capital: Astana Map No. 3771 Rev. 6 UNITED NATIONS January 2004 BASIC DATA Total population (millions) 2009 15.5* Population under age15 (as % of total) 2010 23.8*
COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES
COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES BIRUTE SEMENAITE, MEDICAL DIVISION OF PRISON DEPARTMENT AT THE MINISTRY OF JUSTICE OF THE REPUBLIC OF LITHUANIA LITHUANIAN PRISONS. BACKGROUND:
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.
OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success
XVIII International AIDS Conference, 2010 Vienna UNODC-GTZ Satellite Symposium: OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success Joerg
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
HIV AND PEOPLE WHO INJECT DRUGS
UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.
Harm Reduction in Nigeria
Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous
The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009
The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle
ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)
ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) Project Title: HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Project Number: XEEJ20 Total
The evolution of the HIV/AIDS outbreak among IDUs in Romania
The evolution of the HIV/AIDS outbreak among IDUs in Romania Romanian National Antidrug Agency Romanian National Focal Point on Drugs Andrei Botescu * Lisbon, 12 th October 2012 HIV outbreak among IDU
The impact of economic recession on drug users and drug treatment
The impact of economic recession on drug users and drug treatment Designing and implementing responsive drug policies under fiscal constraints: the case of Greece Meni Malliori Assoc. Prof. of Psychiatry
Intervention from the World Health Organization
Thematic discussion on the implementation of the UNGASS outcome document Operational recommendations on Demand reduction and related measures, including prevention and treatment, as well as other health-related
The italian interactive system for addiction data management
The italian interactive system for addiction data management High risk drug use and drug treatment in Europe 2014 Bruno Genetti Lisbon 24-26 September 2014 Rationale Italian legislation governing drugs
PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS
PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS Holly Hagan, PhD Professor Co-Director, Center for Drug Use and HIV Research Principal Investigator, HCV Synthesis Project New York University HCV prevalence
Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.
Addressing Prevention with HIV Positive Clients This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result in transmitting
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute
Illicit drug use in prisons
Illicit drug use in prisons. Kieran Lynch Criminal Justice Programme Manager.PHE (Acknowledgements: Dr. George Ryan Criminal Justice Clinical Lead for PHE) Key Themes The drugs The people Update on Opiate
As a result of this training, participants will be able to:
Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.
Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse
Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Jay Butler, MD, President of ASTHO, Chief Medical Officer, Alaska Department of Health
COUNTRY TABLE. MONTENEGRO.
EPIDEMIOLOGICAL DATA Indicator Data Source of data/additional notes re data Year of estimate Population 620 029 National Census data 2011 Estimated number of people who inject drugs (PWID) 1282 (95%CI
Felice Nava, MD, PhD Felice A. Nava, MD PhD
Felice Nava, MD, PhD Felice A. Nava, MD PhD Direttore U.O. Sanità Penitenziaria Azienda ULSS 6 Euganea Padova Direttore Comitato Scientifico Nazionale FeDerSerD HCV 0? Dall Eradicazione del virus alla
Compulsory detention as drug treatment and the impact on HIV outcomes
Compulsory detention as drug treatment and the impact on HIV outcomes A Kamarulzaman, J McBrayer University of Malaya, Kuala Lumpur, Malaysia UNODC Scientific Event Science Addressing Drugs And Health:
Technical Guidance Note for Global Fund HIV Proposals
Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United
26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1
The 16 th Core Group Meeting of the TB/HIV Working Group 26 28 May 2010, Almaty, Kazkhstan Nina Kerimi UNODC Regional Project Coordinator 1 UNODC Regional Office for Central Asia covers 6 countries: AZE,
Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia
Part of the Continuum of Care Harm Reduction Gino Vumbaca President Harm Reduction Australia What is Harm Reduction The defining features are the focus on the reduction of harm, rather than on the prevention
Diversion, misuse and trafficking of methadone and buprenorphine: Impact on recovery
Diversion, misuse and trafficking of methadone and buprenorphine: Impact on recovery Hannu Alho, Ph.D., M.D. Professor of Addiction Medicine, University of Helsinki Research Professor, National Institute
Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008
Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality
Substance use and misuse
An open learning programme for pharmacists and pharmacy technicians Substance use and misuse Educational solutions for the NHS pharmacy workforce DLP 160 Contents iii About CPPE open learning programmes
Addiction and Substance misuse pathways
Addiction and Substance misuse pathways Gordon Morse Chief Medical Officer Turning Point UK Gordon Morse statement of interests Sole employer Turning Point Some unpaid advisory work to the Hepatitis C
Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia
Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia Growing evidence in changing of usage, from natural plant substances to synthetic substances
Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine
Natural derivatives of opium poppy - Opium - Morphine - Codeine Opioid Agonists Semi synthetics: Derived from chemicals in opium -Diacetylmorphine Heroin - Hydromorphone Synthetics - Oxycodone Propoxyphene
HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS
POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for
The science of the mind: investigating mental health Treating addiction
The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with
Promoting hepatitis B vaccination
Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis
Statement by the Portuguese Deputy Minister for Health. Vienna, 8 March 2010
Statement by the Portuguese Deputy Minister for Health 53 nd Session of the Commission on Narcotic Drugs Vienna, 8 March 2010 Mr. Chairman, Distinguished Delegates, Ladies and Gentlemen, First, I would
As a result of this training, participants will be able to:
Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result
More than 22,000 people have attended the programs of Dianova
DIANOVA ITALY DIANOVA ONLUS WHO WE ARE Dianova in Italy was established in 1984 and later became an Onlus, which in Italian stands for Non-profit Organization of Social Utility. The organization is dedicated
Educating Courts, Other Government Agencies and Employers About Methadone May 2009
Educating Courts, Other Government Agencies and Employers About Methadone May 2009 The judge said that I won t get my kids back unless I withdraw from methadone. Is that legal? My Probation Officer instructed
OPIOID SUBSTITUTION THERAPY RISKS & BENEFITS
OPIOID SUBSTITUTION THERAPY RISKS & BENEFITS LEO O. LANOIE, MD, MPH, FCFP, CCSAM, ABAM, FISAM, MRO Dr. Leo Lanoie, 2017 DISCLAIMER In the past year I have accepted funds from Purdue for speaking OPIOID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: AUSTRIA Lisbon, 12 th October 201 Epidemiological update 2 HIV notifications in PWID Number of HIV cases
The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015
The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap
Treatment and Harm Reduction in Prisons. Republic of Moldova
Treatment and Harm Reduction in Prisons Republic of Moldova PROJECT REPORT 31 December 2011 The humanity of a society can be judged by the treatment of its prisoners. Winston Churchill in fulfilment of
COUNTRY REPORT BIRUTE SEMENAITE, MEDICAL DIVISION OF THE PRISON DEPARTMENT UNDER THE MINISTRY OF JUSTICE OF THE REPUBLIC OF LITHUANIA
COUNTRY REPORT BIRUTE SEMENAITE, MEDICAL DIVISION OF THE PRISON DEPARTMENT UNDER THE MINISTRY OF JUSTICE OF THE REPUBLIC OF LITHUANIA Tallinn, 16 October 2012 LITHUANIA IN EUROPE area 653.03 km2 population
Drug consumption among roma population
NATIONAL ANTIDRUG AGENCY Drug consumption among roma population High risk drug use and drug treatment in Europe 2014 Special populations and drug problems Lisbon, 24 September 2014 General characteristics
CENTRE FOR RESEARCH EXCELLENCE INTO INJECTING DRUG USE (CREIDU)
CENTRE FOR RESEARCH EXCELLENCE INTO INJECTING DRUG USE (CREIDU) SUBMISSION TO UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON THE WORLD DRUG PROBLEM NOVEMBER 2015 This submission was written by CREIDU
HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015
HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term
Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center
Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers
Introduction. Information for the Committee s consideration
Additional information to the Report to the International Committee on Economic, Social and Cultural Rights on implementation by the Russian Federation of article 12 of the International Covenant on Economic,
Clients profile by groups in France Why to use group classification?
Clients profile by groups in France Why to use group classification? Tanja BASTIANIĆ OFDT 3 avenue du Stade de France 93218 Saint-Denis La Plaine cedex Tel : 01 41 62 77 16 Fax : 01 41 62 77 00 www.ofdt.fr
South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV
14 Original Article South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV Ojha S P 1, Sigdel S 2, H-G M 3, Verthein U 4 1 Tribhuvan University Teaching Hospital,
HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons
HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons Ministerial Meeting on Urgent response to the HIV/AIDS epidemics in the Commonwealth of Independent States Moscow, 31 March
Benzodiazepine Misuse Abuse - Dependence Using for recreational purposes Continued long term use against medical advise Use of drug with other potenti
Benzodiazepine Prescribing In Primary Care Settings: Issue for Concern? Louis E. Baxter, Sr., M.D., FASAM Executive Medical Director Professional Assistance Program, New Jersey, Inc. Benzodiazepine Misuse
China Country Advocacy Brief Injecting Drug Use and HIV
United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific China Country Advocacy Brief Injecting Drug Use and HIV Key actions to be supported Expansion of the national
Thirty years of harm reduction in the Netherlands HCV elimination ahead?
Thirty years of harm reduction in the Netherlands HCV elimination ahead? Esther Croes, MD PhD Confession 30 years 3 topics: drug use, harm reduction, HCV in 15 minutes IT DOESN T FIT!! 2 Disclosure Esther
Regional Program Harm Reduction Works Fund It! Baseline assessment. Country: Georgia. Preliminary analysis. 10 October 2014
Regional Program Harm Reduction Works Fund It! Baseline assessment Country: Georgia Preliminary analysis 10 October 2014 Main constraints The formation of representative bodies, such is CCM, is not transparent.
1/5 of world s population 40% of world s poor 400 million < USD 1/day >11 million drug users & > 3.6 million opiate users
UNODC in South Asia 2010 UNODC SOUTH ASIA South Asia -Facts & Figures 1/5 of world s population 40% of world s poor 400 million < USD 1/day >11 million drug users & > 3.6 million opiate users 1 Approx.
The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines
The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs
Building capacity for a CHC response to Ontario's Opioid Crisis
Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC
LITERATURE REVIEW: BULGARIA
Directorate-General Justice, Freedom and Security LITERATURE REVIEW: BULGARIA THROUGHCARE WORKING IN PARTNERSHIP 1 CONTENTS 1.Drug use 3 1.1 Trends and statistics 3 1.2 Drug use amongst specific groups
Improving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative
Improving NSP and Harm Reduction Services Jason Farrell, European HCV and Drug Use Initiative Presentation Overview With the growing need to treat HCV, NSP programs have been identified in numerous stakeholder
Understanding Key Populations: Removing Legal Barriers to Prisons Health and Human Rights. Nthabiseng Mokoena
Understanding Key Populations: Removing Legal Barriers to Prisons Health and Human Rights. Nthabiseng Mokoena Key Populations The World health Organisation (WHO) defines key populations as groups who,
Swedish drug policy a balanced policy based on health and human rights
Swedish drug policy a balanced policy based on health and human rights Swedish drug policy a balanced policy based on health and human rights Sweden s drug policy has been firmly established for a long
Vivitrol/Suboxone. Comparison Study Summary
Vivitrol/Suboxone Comparison Study Summary Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., & King, J. (2017). Comparative effectiveness of extended-release naltrexone versus
Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies
Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Wendee Wechsberg, PhD, Senior Director Substance Abuse Treatment Evaluations and Interventions
FACT SHEET SERBIA (REPUBLIC OF)
FACT SHEET SERBIA (REPUBLIC OF) Territory: Borders: 88,509 sq. km 2,362 km (total) Hungary: 175 km, Romania: 548 km, Bulgaria: 361 km, FYR of Macedonia: 283 km, Albania: 114 km, Montenegro: 249 km, Bosnia
What is harm reduction?
What is harm reduction? The International Harm Reduction Association (IHRA) defines harm reduction as the policies, programmes and practices that aim to reduce the harms associated with the use of psychoactive
Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story
Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Sarah Sharfstein Kawasaki, MD Director of Addictions Services, Pennsylvania Psychiatric
The Pillars Approach: A Case Study
The Pillars Approach: A Case Study Dorothy J. Chaney, M.Ed. CADCA Trainer www.cadca.org Building Safe, Healthy, and Drug Free Communities Learning Objectives Discover how the pillars approach utilizes
About Project Sunrise
1 2 About Project Sunrise FHI 360 has been awarded a five year project titled Sunrise by the Centers for Disease Control and Prevention (CDC). The project aims to complement the ongoing National AIDS Control
Injecting Drug Users in Indonesia : Towards a Comprehensive Care
Injecting Drug Users in Indonesia : Towards a Comprehensive Care Introduction The prevalence of HIV/AIDS and other viral blood/borne transmitted infections such as Hepatitis B and C has greatly increased
European Legal Database on Drugs
European Legal Database on Drugs / Reviewing legal aspects of substitution treatment at international level Prepared by the EMCDDA at the request of the Pompidou Group Secretariat EMCDDA ELDD Comparative
ATLAS on substance use 2017:
WHO Forum on alcohol, drugs and addictive behaviours Enhancing public health actions through partnerships and collaboration ATLAS on substance use 17: resources for the prevention and treatment of substance
How does polydrug use contribute to heroin overdose deaths? Risk to heroin users of concurrent use of pregabalin and gabapentin
How does polydrug use contribute to heroin overdose deaths? Risk to heroin users of concurrent use of pregabalin and gabapentin Graeme Henderson Suzanne Audrey Matt Hickman Abi Lyndon Rob Hill Claudia
OVERVIEW OF PRESENTATION
OVERVIEW OF PRESENTATION Trends Methodology Key messages from public consultation Vision Values, Goals, s Performance Measurement System Health-led actions Structures supporting delivery DRUG AND ALCOHOL
POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE. Last data available Indicator (sphere)
POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE Amendments in laws and legal regulations number 8 2 NDC Expenditures for activities against drugs and drug addictions in Bulgaria [1] BGN 1 102
Vivitrol Vs. Suboxone
Vivitrol Vs. Suboxone Vivitrol - Naltrexone Indicated for opiate dependence and alcohol withdrawal pure antagonist 380mg once every 4 weeks IM Peak plasma concentration in 2 hrs, followed by a second peak
What is injection drug use?
What is injection drug use? Essential Standards 7.ATOD.1 Understand the health risks associated with alcohol, tobacco, and other drug use. Clarifying Objectives 7.ATOD.1.2 - Explain health risks resulting
RESULTS OF THE DRUG ABUSE MONITORING SURVEY WITHIN CORRECTIONAL FACILITIES IN BERMUDA
Regional Workshop on Drug Information Networks (DINs) RESULTS OF THE DRUG ABUSE MONITORING SURVEY WITHIN CORRECTIONAL FACILITIES IN BERMUDA Antigua & Barbuda 2 nd August, 2012 Dr. Kyla Raynor Senior Research
Decriminalization of Personal Use of Psychoactive Substances
DRAFT POSITION STATEMENT Decriminalization of Personal Use of Psychoactive Substances The use of illegal psychoactive substances (IPS) in Canada persists despite ongoing efforts to limit their consumption.
Place of addiction-informed comprehensive treatment in HIV care
Place of addiction-informed comprehensive treatment in HIV care Cecile Denis, PhD Center for Studies of Addiction, University of Pennsylvania, Philadelphia, USA University of Bordeaux, Bordeaux, France
Making the world safer from drugs, crime and terrorism
World Drug Report 2017 Briefing to the Member States and Civil Society Organizations Geneva, 22 June 2017 Aldo Lale-Demoz, UNODC Deputy Executive Director UNODC is pleased to present the findings of the
HARM REDUCTION & TREATMENT. Devin Reaves MSW
HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that
Historical Perspectives
Why Harm Reduction? 1 Rochelle Head-Dunham, MD FAPA Executive Director and Medical Director Metropolitan Human Services District Clinical Associate Professor of Psychiatry LSU and Tulane Historical Perspectives
Our dilemma is that we hate change and love it at the same time; what we really want is for things to remain the same but get better.
Our dilemma is that we hate change and love it at the same time; what we really want is for things to remain the same but get better. Sydney J. Harris A common but not so constructive response to pressing
Drugs and infection risks: challenges and prospects for West Africa the Senegalese Experience.
Drugs and infection risks: challenges and prospects for West Africa the Senegalese Experience. Dr Idrissa BA Psychiatrist addictionologist CEPIAD (Centre for Integrated Addiction Treatment) Technical Coordinator
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Methadone and buprenorphine for the management of opioid dependence
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Appraisal Methadone and buprenorphine for the management of opioid dependence Comments received from Consultees and Commentators on the draft scope
ORGANIZATION OF AMERICAN STATES
ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic
Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations
cessation of use may be the most effective form of harm reduction but, in reality, many clients do not wish to cease using, or find it too difficult. (Addy & Ritter, 2000, p.1) Introduction Historically,
Other Models of Addictions Treatment
Overview Other Models of Addictions Treatment Psychology 470 Introduction to Chemical Additions Steven E. Meier, Ph.D. Many types of models Harm Reduction Enforcement models Economic Models Sociological
Harm Reduction. Christopher Shaw, PMHNP Massachusetts General Hospital.
Harm Reduction Christopher Shaw, PMHNP Massachusetts General Hospital Harm Reduction Harm reduction (HR) refers to the policies, programs and practices that aim primarily to reduce the adverse health,
Version for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres
HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres Objectives The Epidemiology of HIV/AIDS in the EECA Region (Trends) o The Burden of HIV/AIDS
who use drugs in order to assist them in reducing harm while in the cycle of addiction
August 16, 2016 } Accepts that illicit drug use is part of our world, and chooses to minimize its harmful effects rather than ignore or condemn them } Calls for the provision of services to people who
Harm Reduction. Christopher Shaw, PMHNP Massachusetts General Hospital.
Harm Reduction Christopher Shaw, PMHNP Massachusetts General Hospital Disclosures Neither I nor my spouse/partner has a relevant financial relationship with a commercial interest to disclose. Harm Reduction
Template Control Page. Substance Misuse Newham Template Guide. Substance Misuse Newham. Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY
Template Control Page Substance Misuse Newham Template Guide Title Substance Misuse Newham Author CEG Status Active Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY Version Date Summary of Changes
Part 1: Introduction & Overview
Part 1: Introduction & Overview We envision a collaborative, participative partnership around IDU that: Provides all relevant and interested stakeholders with a voice and role. Promotes awareness of the
Pilot Condom Distribution in Czech Prison
Pilot Condom Distribution in Czech Prison Viktor Mravčík, Heike Zurhold, Tomáš Koňák, Barbara Janíková, Kateřina Grohmannová, Tereza Černíková, Marcus Martens, Heino Stöver Background (2): Czech Prison